Makary’s Expert Panel Sparks Regulatory Action For Menopause Hormonal Therapy

 
• By Sarah Karlin-Smith
  
FDA Commissioner Martin Makary announced changes to hormone replacement therapy labeling on Nov. 10. (Sarah Karlin-Smith)

More from Drug Safety

More from US FDA